Nuix rev for FY23 was $182.5m, with the growth we know about from the May update that FY24 EBITDA is up 35% and ACV is up 10% on 23 + the one-off insurance sugar-hit. So a 20% Nett Revenue growth is not unreasonable.
What is the PE for this category on $220m Rev and growing conservatively at 15-20% PA?
DYOR.
Nuix rev for FY23 was $182.5m, with the growth we know about...
-
- There are more pages in this discussion • 33 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NXL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.75 |
Change
0.040(0.85%) |
Mkt cap ! $1.560B | |||
| Open | High | Low | Value | Volume |
| $4.80 | $4.93 | $4.75 | $5.728M | 1.187M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10523 | $4.75 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.78 | 46839 | 1 |
View Market Depth
| Last trade - 16.10pm 26/08/2024 (20 minute delay) ? |
| NXL (ASX) Chart |